saged

Lee has experienced anxiety for much of her adult life, but her symptoms have recently intensified—interfering with work, sleep, and daily functioning. Having previously trialled SSRIs with limited success, she is now exploring medical cannabis as a potential treatment option. This case study follows Lee’s clinical assessment and treatment planning process, highlighting the key factors considered by her healthcare team in determining suitability for medical cannabis. Practitioners will examine how THC and CBD interact with anxiety symptoms, how patient history informs treatment planning, and what safety precautions are critical in minimising adverse effects—particularly with THC. The module also explores regulatory considerations under the TGA framework and provides practical guidance on how to approach patient education and shared decision-making when discussing medical cannabis for anxiety management. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Discuss the relationship between THC, CBD and anxiety Discuss the TGA requirements, potential benefits and limitations of medical cannabis as a treatment option for anxiety Identify patients with anxiety who are suitable candidates for medical cannabis treatment Collect detailed patient information Apply critical safety considerations and provide patient education and treatment advice regarding medical cannabis treatment for anxiety  Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management for anxiety

Zoey, a 46 year old female is seeking treatment for her chemotherapy-related symptoms. Zoey is currently undergoing chemotherapy as she was diagnosed with breast cancer at the start of 2023. There is risk of hepatic injury as medical cannabis and chemotherapy can both effect the liver.  This case study explores how Zoey's team managed the symptoms of her chronic pain, fatigue, low mood and lack of appetite using medical cannabis to to combat Zoey's chemotherapy symptoms and regain her sense of self.  Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptomatic management of chemotherapy and breast cancer Identify suitable candidates for medical cannabis treatment Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of Breast cancer and chemotherapy Apply critical safety considerations & provide patient education & treatment advice regarding MC treatment

Rachel, a 40-year-old female, presents with migraines, insomnia and chronic abdominal pain secondary to a recent nephrectomy due to chronic kidney disease.After trying many medications with only minimal symptom relief, Rachel’s desperate to find an alternative solution.In this case study, we explore how Rachel’s team prescribed medical cannabis to help manage her pain and insomnia and improve her overall quality of life. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain how and why chronic renal kidney disease affects patients Discuss the potential benefits and limitations of medical cannabis as a treatment option for chronic renal kidney disease, nephrectomy, migraines and nausea and vomiting Identify suitable candidates for medical cannabis treatment Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of chronic renal disease, nephrectomy, migraines, nausea and vomiting Devise treatment plans that consider patient safety and minimise risk Offer effective patient education and treatment advice on the therapeutic use of medical cannabis

Mario, a 40-year-old male presents with respiratory symptoms and sleep difficulties associated with his diagnosis of chronic obstructive pulmonary disease.After being hospitalised 3 times in recent months, despite following his current treatment plan, Mario is seeking a more effective solution.In this case study, we explore how Mario’s team prescribed non-inhaled medical cannabis products to treat his respiratory symptoms, restore his sleep quality, and improve his quality of life. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the pathophysiology of COPD and identify common management strategies Discuss the potential benefits and limitations of medical cannabis as a treatment option for patients with COPD Identify suitable candidates for medical cannabis treatment Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of COPD Devise treatment plans that consider patient safety and minimise risk Offer effective patient education and treatment advice on the therapeutic use of medical cannabis

Fifty-six year old Stephen, an avid gardener, has hit a rough patch. He’s out of action because of the chronic pain in his back, and gout pain in his wrists and ankles. He’s considering medical cannabis as a therapeutic option. The complication? He has hepatic fibrosis from fatty liver of moderate severity, resulting in reduced hepatic function. In this case study, explore how his team safely prescribed medical cannabis to Stephen, helping him manage his pain and get back onto his feet – and into his garden. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain how medical cannabis interacts with the body, including the mechanisms of action and metabolism Apply critical safety considerations / risk mitigation strategies for patients presenting with hepatic dysfunction or impairment Discuss the potential benefits and limitations of medical cannabis as a treatment option for patients with hepatic dysfunction Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management Educate patients (on their individual case) on how to safely apply their treatment with medical cannabis

Sixty-year-old Jen was hesitant when she walked into the consultation room. She had been experiencing severe ankle pain caused by chronic regional pain syndrome and her treatments to date hadn’t done the trick. But medical cannabis? Wouldn’t she end up walking around “like a zombie”? To complicate matters further, Jen has a history of now-stable cardiovascular disease. THC and CBD can affect cardiac functioning and interact with common POAC drugs.  But, all hope was not lost! In this case study, find out how Jen’s team safely treated her pain and secondary insomnia using medical cannabis, and minimised psychotropic effects so she remained her lively, vital self throughout treatment. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the cardiac effects of medical cannabis Discuss the potential benefits and limitations of medical cannabis as a treatment option in patients with cardiac disease Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management Apply critical safety considerations/risk mitigation strategies for patients presenting with cardiac concerns Discuss potential drug-drug interactions Provide medication safety education to patients around drug-drug interactions

Gina, a 32-year-old with endometriosis, seeks treatment for her gastrointestinal and pain-related symptoms.  Gina has tried a range of conventional medications and therapies, but they’ve offered little relief for her symptoms, in particular her pain which leaves her cyclically incapacitated and impacts her work as a hotel manager. In this case study, we explore how Gina’s team prescribed medical cannabis products to help Gina manage her pain and reduce the impacts on her work and wellbeing. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the pathophysiology of endometriosis  and identify common management strategies  Discuss the potential benefits and limitations of medical cannabis as a treatment option for common symptoms of endometriosis Identify suitable candidates for medical cannabis treatment Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of endometriosis Devise treatment plans that consider patient safety and minimise risk Offer effective patient education and treatment advice on the therapeutic use of medical cannabis

Jen, a 21 year old woman experiences a couple of seizures per week due to photosensitive epilepsy. This case study explores how Jen's team helped her reduce the duration and the frequency of her seizures with medical cannabis. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Demonstrate an understanding of safe prescribing and risks associated with medical cannabis and Epilepsy  Assess the suitability of cannabis treatment in patients with Epilepsy  Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management Monitor and provide titration advice around cannabinoid medicines Apply critical safety considerations in patient centred care Navigate the regulatory frameworks surrounding medical cannabis provision in Australia

Fibromyalgia (FMS) is a heterogeneous condition characterised by chronic pain throughout the body and is commonly associated with a range of other conditions and symptoms. It’s estimated that there are 1 million Australians with FMS and it’s more common in women than men. In this case study, Jordan, a 32-year-old with FMS, seeks treatment for anxiety and chronic pain. Jordan experienced pain relief while medicated in hospital, but since then hasn't found a solution. The pain and stress is beginning to impact their sleep and daily living.  In this case study, we explore how Jordan was prescribed medical cannabis oil products to help them manage their symptoms and improve their quality of life. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the pathophysiology of fibromyalgia and identify common management strategies Discuss the potential benefits and limitations of medical cannabis as a treatment option for common symptoms of fibromyalgia  Identify suitable candidates for medical cannabis treatment Devise treatment plans that consider patient safety and minimise risk Offer effective patient education and treatment advice on the therapeutic use of medical cannabis

Lauren is a 35-year-old with hypermobile Ehlers-Danlos Syndrome (hEDS). Despite currently trying to manage her symptoms with a wide range of pharmaceutical and non-pharmaceutical interventions, Lauren is still experiencing pain, sleep problems, moments of low mood and nausea. These symptoms are stopping her from being able to fully participate in life. In this case study, we explore how Lauren's team prescribed medical cannabis products to help her manage her symptoms so she can enjoy life day-to-day. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the pathophysiology of EDS and identify common management strategies  Discuss the potential benefits and limitations of medical cannabis as a treatment option for common symptoms of EDS Identify suitable candidates for medical cannabis treatment Devise treatment plans that consider patient safety and minimise risk Offer effective patient education and treatment advice on the therapeutic use of medical cannabis

46 year old Robert is dealing with a lot of stress at work. This is affecting his quality of sleep. Explore how Robert's team helped him combat situational stress and prescribed medical cannabis to improve his overall sleep quality. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptomatic management of patients with insomnia Identify suitable candidates for medical cannabis treatment Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management for insomnia Apply critical safety considerations & provide patient education & treatment advice regarding MC treatment

Sixty-six-year-old David was diagnosed with irritable bowel syndrome (IBS) after hospitalisation for diverticulitis in 2016. He experiences abdominal pain, nausea, constipation, gas and bloating after meals. Stress exacerbates these symptoms. David has trialled several first-line treatments, including various dietary modifications, but none adequately relieved his symptoms. In this case study, we explore how Dr. Xie prescribed medical cannabis products to manage David’s symptoms and help to improve his quality of life. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the pathophysiology of IBS  and identify common management strategies  Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptoms of IBS Identify suitable candidates for medical cannabis treatment Devise treatment plans that consider patient safety and minimise risk Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in the management of IBS